Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Amyotrophic Lateral Sclerosis

View through CrossRef
Abstract Amyotrophic lateral sclerosis is a progressive neurodegenerative syndrome characterized by loss of motor neurons. Cognitive impairment occurs in a significant proportion of those affected. Numerous theories of pathogenesis have been advanced. The most cogent hypothesis is that genetic susceptibilities to neurodegeneration interact with environmental exposures, leading to neuronal injury, glial activation and neuronal death. Modern tools of molecular and cell biology and constructive international collaborations have provided insights into the factors that increase disease susceptibility. The important observation that genes associated with ribonucleic acid (RNA) processing are implicated in disease pathogenesis will undoubtedly influence the direction of research in the coming years. These factors, combined with improvements in clinical trial design, and an improved understanding of the limitations of translating positive findings from animal models to human subjects, are likely to lead to new and successful therapeutic options for patients in the near future. Key concepts: Amyotrophic lateral sclerosis is a motor system degeneration. The incidence of amyotrophic lateral sclerosis is relatively uniform in populations of European ancestry. Disease frequency is lower in populations of mixed ancestry. Amyotrophic lateral sclerosis (ALS) is associated with cognitive decline in up to 50% of cases, and with dementia in up to 20%. There is an acknowledged clinical, imaging, neuropathologic and neurogenetic overlap between ALS and frontotemporal dementia. Amyotrophic lateral sclerosis is a complex genetic condition, in which genetic susceptibility interacts with environmental exposures to produce a neurodegenerative cascade. The progression of amyotrophic lateral sclerosis is due in part to the activation of glia, which contributes to the process of neurodegeneration. Recent genetic studies of amyotrophic lateral sclerosis have implicated genes involving RNA regulation, including transcription, RNA splicing, RNA transport and translation.
Title: Amyotrophic Lateral Sclerosis
Description:
Abstract Amyotrophic lateral sclerosis is a progressive neurodegenerative syndrome characterized by loss of motor neurons.
Cognitive impairment occurs in a significant proportion of those affected.
Numerous theories of pathogenesis have been advanced.
The most cogent hypothesis is that genetic susceptibilities to neurodegeneration interact with environmental exposures, leading to neuronal injury, glial activation and neuronal death.
Modern tools of molecular and cell biology and constructive international collaborations have provided insights into the factors that increase disease susceptibility.
The important observation that genes associated with ribonucleic acid (RNA) processing are implicated in disease pathogenesis will undoubtedly influence the direction of research in the coming years.
These factors, combined with improvements in clinical trial design, and an improved understanding of the limitations of translating positive findings from animal models to human subjects, are likely to lead to new and successful therapeutic options for patients in the near future.
Key concepts: Amyotrophic lateral sclerosis is a motor system degeneration.
The incidence of amyotrophic lateral sclerosis is relatively uniform in populations of European ancestry.
Disease frequency is lower in populations of mixed ancestry.
Amyotrophic lateral sclerosis (ALS) is associated with cognitive decline in up to 50% of cases, and with dementia in up to 20%.
There is an acknowledged clinical, imaging, neuropathologic and neurogenetic overlap between ALS and frontotemporal dementia.
Amyotrophic lateral sclerosis is a complex genetic condition, in which genetic susceptibility interacts with environmental exposures to produce a neurodegenerative cascade.
The progression of amyotrophic lateral sclerosis is due in part to the activation of glia, which contributes to the process of neurodegeneration.
Recent genetic studies of amyotrophic lateral sclerosis have implicated genes involving RNA regulation, including transcription, RNA splicing, RNA transport and translation.

Related Results

Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration
Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration
Abstract TDP-43 is mislocalized from the nucleus and aggregates within the cytoplasm of affected neurons in cases of amyotrophic lateral sclerosis. TDP-43 pathology ...
Urinary biomarkers for amyotrophic lateral sclerosis: candidates, opportunities and considerations
Urinary biomarkers for amyotrophic lateral sclerosis: candidates, opportunities and considerations
Abstract Amyotrophic lateral sclerosis is a relentless neurodegenerative disease that is mostly fatal within 3–5 years and is diagnosed on evidence of progressive up...
Amyotrophic Lateral Sclerosis and its Masks, a Comorbid Pathology with a Rapid Fatal Outcome: Case Report
Amyotrophic Lateral Sclerosis and its Masks, a Comorbid Pathology with a Rapid Fatal Outcome: Case Report
INTRODUCTION. Despite the fact that more than 150 years have passed since the first mention of amyotrophic lateral sclerosis (ALS), the issues of etiology, pathogenesis, diagnosis ...
Hydatid Cyst of The Orbit: A Systematic Review with Meta-Data
Hydatid Cyst of The Orbit: A Systematic Review with Meta-Data
Abstarct Introduction Orbital hydatid cysts (HCs) constitute less than 1% of all cases of hydatidosis, yet their occurrence is often linked to severe visual complications. This stu...
Clinical features of fatigue in amyotrophic lateral sclerosis
Clinical features of fatigue in amyotrophic lateral sclerosis
Background. Fatigue (athenia) is widely spread among patients with neurological disorders. It substantially reduces patients’ quality of life. Its clinical features and mechanisms ...
Frequency of Dementia in Patients with Amyotrophic Lateral Sclerosis
Frequency of Dementia in Patients with Amyotrophic Lateral Sclerosis
Objective: To determine the frequency of dementia in patients with amyotrophic lateral sclerosis. Study Design: Cross-sectional study Place and Duration of Study: Department of Neu...
Mast cells and neuroinflammation in pathogenesis of neurologic and psychiatric diseases
Mast cells and neuroinflammation in pathogenesis of neurologic and psychiatric diseases
The review summarizes current data on the role of neuroinflammation and mast cells in the pathogenesis of nervous and mental diseases, such as multiple sclerosis, Alzheimers diseas...

Back to Top